These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7786880)

  • 21. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine treatment of panic disorder with agoraphobia: the second time around.
    Mavissakalian MR; Perel JM; de Groot C
    J Psychiatr Res; 1993; 27(1):61-8. PubMed ID: 8515390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High plasma concentrations of paroxetine impede clinical response in patients with panic disorder.
    Watanabe T; Ueda M; Saeki Y; Hirokane G; Morita S; Okawa M; Akiyama K; Shimoda K
    Ther Drug Monit; 2007 Feb; 29(1):40-4. PubMed ID: 17304148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonazepam in the treatment of patients with recurrent panic attacks.
    Beaudry P; Fontaine R; Chouinard G; Annable L
    J Clin Psychiatry; 1986 Feb; 47(2):83-5. PubMed ID: 3944069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
    Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
    J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paroxysmal neurological manifestations disclosing panic attacks].
    Petiau C; Hirsch E; Peretti S; Sellal F; Hammouti A; Danion JM; Marescaux C
    Rev Neurol (Paris); 1992; 148(8-9):555-9. PubMed ID: 1362998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin and panic disorders: a review of clinical studies.
    Norman TR; Burrows GD; Judd FK; McIntyre IM
    Int J Clin Pharmacol Res; 1989; 9(2):151-7. PubMed ID: 2654037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
    Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newer antidepressants and panic disorder: a meta-analysis.
    Andrisano C; Chiesa A; Serretti A
    Int Clin Psychopharmacol; 2013 Jan; 28(1):33-45. PubMed ID: 23111544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tritiated imipramine binding to platelets is decreased in patients with agoraphobia.
    Lewis DA; Noyes R; Coryell W; Clancy J
    Psychiatry Res; 1985 Sep; 16(1):1-9. PubMed ID: 2997822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipramine binding in platelets of patients with panic disorder.
    Marazziti D; Rotondo A; Placidi GF; Perugi G; Cassano GB; Pacifici GM
    Pharmacopsychiatry; 1988 Jan; 21(1):47-9. PubMed ID: 3362963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a new statistical approach to evaluate a clinical trial with panic disorder patients.
    Bandelow B; Brunner E; Beinroth D; Pralle L; Broocks A; Hajak G; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):21-7. PubMed ID: 10195340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ; Endler NS; Lee PS; Swinson RP
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks.
    Schneider LS; Munjack D; Severson JA; Palmer R
    Biol Psychiatry; 1987 Jan; 22(1):59-66. PubMed ID: 3790641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-life-onset panic disorder: clinical and demographic characteristics of a patient sample.
    Hassan R; Pollard CA
    J Geriatr Psychiatry Neurol; 1994; 7(2):84-8. PubMed ID: 8204193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dissociative experiences on drug treatment of panic disorder.
    Gulsun M; Doruk A; Uzun O; Turkbay T; Ozsahin A
    Clin Drug Investig; 2007; 27(8):583-90. PubMed ID: 17638399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.